May 14, 2015. We enthusiastically support increased transparency with patients during the informed consent process about the risks of infection transmission during the ERCP procedure. Patients are entitled to full disclosure of the potential risks of any procedure or treatment they receive.
Read More »On Health Policy
Letter to the Dietary Guidelines for Americans Committee (DGAC) Regarding the Dietary Guidelines for Americans (DGA)
May 8, 2015. NCHR gives our opinion on the expert report prepared for the eighth edition of the Dietary Guidelines for Americans (DGA) by the Dietary Guidelines for Americans Committee (DGAC). Overall, we strongly support the conclusions and policy recommendations in the report.
Read More »NCHR Testimony on the Dietary Guidelines Advisory Committee’s Report
March 24, 2015. We strongly agree with the Dietary Guidelines Advisory Committee’s report of a healthy diet as one that is: higher in fruits, vegetables, whole grains, low-fat dairy, seafood, legumes, and nuts; lower in red and processed meats; low in sugar-sweetened foods and drinks; and lower in sodium.
Read More »Comments on Transfer of Premarket Notification Clearance
March 23, 2015. We support the draft guidance with one suggested revision to Section V to help in clarifying who currently holds a 510(k) device. Overall, this guidance will help to ensure that the public information in the FDA’s 510(k) databases are accurate and up-to-date, including the most current owner of a 510(k) device.
Read More »Analysis of Impact of Device Excise Tax on U.S.-Based Medical Device Companies
April 16, 2015. The purpose of the 2.3% excise tax on medical devices, which was implemented in January 2013, is to raise revenue to help support health insurance coverage for the millions of Americans who have been unable to afford it.
Read More »